
Did President Trump’s December 18, 2025 executive order eliminate 280E taxes for cannabis businesses? No. This page explains what the order actually did, the legal steps required to reschedule marijuana to Schedule III, when 280E would truly change, and what Schedule III could mean for NY dispensaries.
On December 18, 2025, President Trump signed an executive order directing the Attorney General to move forward with rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act.
An executive order can instruct federal agencies to act.
It cannot directly rewrite federal statutes or instantly change drug scheduling.
Marijuana does not become Schedule III until the federal rulemaking process is completed and a final rule becomes effective.
An executive order:
Only Congress or a completed DEA rulemaking process can change marijuana’s schedule under federal law.
Until that process is finished, marijuana remains Schedule I.
Rescheduling requires a formal administrative process under federal law:
Nothing changes legally until a final rule is published and becomes effective.
Headlines do not change the tax code.
Internal Revenue Code §280E applies to businesses trafficking in Schedule I or II controlled substances.
If marijuana is officially moved to Schedule III through final rulemaking, 280E would no longer apply to marijuana because the statute is limited to Schedule I and II substances.
Key point:
280E does not disappear because of an executive order.
280E changes only if:
Until then, cannabis businesses must continue filing under 280E.
Schedule III substances are still federally controlled drugs.
They are not “legalized.”
Schedule III classification recognizes accepted medical use and lowers some regulatory barriers compared to Schedule I.
However, this does not automatically make state adult-use dispensaries federally compliant.
Rescheduling to Schedule III does not automatically authorize:
Federal legality and scheduling are not the same thing.
Schedule III drugs typically operate within federal prescription and DEA registration frameworks.
Marijuana is not automatically transformed into an FDA-approved drug product.
Rescheduling does not automatically convert dispensaries into pharmacies.
However, federal recognition of medical use may increase long-term pressure toward tighter federal standards.
Rescheduling may reduce institutional risk perception.
But banks still evaluate:
Rescheduling does not remove monitoring.
Federal bankruptcy is governed by federal law.
Courts have historically struggled with marijuana-related businesses due to federal illegality.
Rescheduling alone may not eliminate bankruptcy uncertainty for THC retailers.
Build your financial systems based on current law, not anticipated changes.